Literature DB >> 993094

Complications of irradiation related to apparent drug potentiation by adriamycin.

E G Mayer, C A Poulter, S A Aristizabal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 993094     DOI： 10.1016/0360-3016(76)90091-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  13 in total

1.  Characteristics and effect of antiinflammatory drugs on adriamycin-induced inflammation in the mouse paw.

Authors:  D M Siegel; S N Giri; R M Scheinholtz; L W Schwartz
Journal:  Inflammation       Date:  1980-06       Impact factor: 4.092

2.  Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics.

Authors:  M J Soble; R T Dorr; P Plezia; S Breckenridge
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 3.  Docetaxel-induced radiation recall dermatitis : A case report and literature review.

Authors:  Iosif Strouthos; Nikolaos Tselis; Nikolaos Zamboglou
Journal:  Strahlenther Onkol       Date:  2016-06-10       Impact factor: 3.621

Review 4.  Radiation recall with anticancer agents.

Authors:  Howard A Burris; Jane Hurtig
Journal:  Oncologist       Date:  2010-11-02

5.  Radiation recall dermatitis: case report and review of the literature.

Authors:  A E Hird; J Wilson; S Symons; E Sinclair; M Davis; E Chow
Journal:  Curr Oncol       Date:  2008-01       Impact factor: 3.677

6.  The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial.

Authors:  C Blomqvist; K Tiusanen; I Elomaa; P Rissanen; T Hietanen; E Heinonen; P Gröhn
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

7.  Renal and haemopoietic proliferative defects as a delayed consequence of cis-platin, adriamycin and daunomycin treatments.

Authors:  P G Braunschweiger; C J Kovacs; L L Schenken
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

8.  Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells.

Authors:  Y Tao; P Zhang; V Frascogna; Y Lecluse; A Auperin; J Bourhis; E Deutsch
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640

9.  Docetaxel-induced radiation recall dermatitis with atypical features: A case report.

Authors:  Masakuni Sakaguchi; Toshiya Maebayashi; Takuya Aizawa; Naoya Ishibashi
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

10.  Additive interaction of gefitinib ('Iressa', ZD1839) and ionising radiation in human tumour cells in vitro.

Authors:  N Giocanti; C Hennequin; D Rouillard; R Defrance; V Favaudon
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.